PPARγ activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells

Biochemical and Biophysical Research Communications

Volumn 402, Issue 3, 2010, Pages 477-482

  Mogilenko, Denis A ^a,b   Shavva, Vladimir S ^b   Dizhe, Ella B ^a   Orlov, Sergey V ^a,b   Perevozchikov, Andrej P ^a,b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

ABCA1; HDL; LXR; MEK1 2; PPAR

Indexed keywords

ABC TRANSPORTER A1; CELL NUCLEUS RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CANCER CELL; CELL STRAIN HEPG2; DOWN REGULATION; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN FUNCTION;

ATP-BINDING CASSETTE TRANSPORTERS; BENZOPHENONES; CELL NUCLEUS; DOWN-REGULATION; HEP G2 CELLS; HUMANS; LIVER; MAP KINASE KINASE 1; MAP KINASE KINASE 2; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TYROSINE;

MAMMALIA;

EID: 78549284241     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.053     Document Type: Article

References (25)

1. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 1995, 36:211-228.
2. Brewer H.B. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24:387-391.
3. Lewis G.F., Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 2005, 96:1221-1232.
4. Joyce C., Freeman L., Brewer H.B., Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:965-971.
5. Wang N., Tall A.R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1178-1184.
6. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest J., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999, 22:336-345.
7. Serfaty-Lacrosniere C., Civeira F., Lanzberg A., Isaia P., Berg J., Janus E.D., Smith M.P., Pritchard P.H., Frohlich J., Lees R.S., et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994, 107:85-98.
8. Aiello R.J., Brees D., Francone O.L. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 2003, 23:972-980.
9. Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation. Curr. Opin. Lipidol. 2005, 16:19-25.
10. Wellington C.L., Brunham L.R., Zhou S., Singaraja R.R., Visscher H., Gelfer A., Ross C., James E., Liu G., Huber M.T., Yang Y.Z., Parks R.J., Groen A., Fruchart-Najib J., Hayden M.R. Alterations of plasma lipids in mice via adenoviral mediated hepatic overexpression of human ABCA1. J. Lipid Res. 2003, 44:1470-1480.
11. Schmitz G., Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta 2005, 1735:1-19.
12. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 1999, 104:R25-R31.
13. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 2000, 275:28240-28245.
14. Ogata M., Tsujita M., Hossain M.A., Akita N.U., Gonzalez F.J., Staels B., Suzuki S., Fukutomi T., Kimura G., Yokoyama S. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 2009, 205:413-419.
15. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 2001, 7:161-171.
16. Hossain M.A., Tsujita M., Gonzalez F.J., Yokoyama S. Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes. J. Cardiovasc. Pharmacol. 2008, 51:258-266.
17. Hozoji M., Munehira Y., Ikeda Y., Makishima M., Matsuo M., Kioka N., Ueda K. Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux. J. Biol. Chem. 2008, 283:30057-30063.
18. Mogilenko D.A., Dizhe E.B., Shavva V.S., Lapikov I.A., Orlov S.V., Perevozchikov A.P. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells. Biochemistry 2009, 48:11950-11960.
19. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., Chen M., Noh G., Goodman J., Hagger G.N., Tran J., Tippin T.K., Wang X., Lusis A.J., Hsueh W.A., Law R.E., Collins J.L., Willson T.M., Tontonoz P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 2002, 99:7604-7609.
20. Naik S.U., Wang X., Da Silva J.S., Jaye M., Macphee C.H., Reilly M.P., Billheimer J.T., Rothblat G.H., Rader D.J. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006, 113:90-97.
21. Huang W.C., Chio C.C., Chi K.H., Wu H.M., Lin W.W. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp. Cell Res. 2002, 277:192-200.
22. Zhou X., Yin Z., Guo X., Hajjar D.P., Han J. Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J. Biol. Chem. 2010, 285:6316-6326.
23. Szanto A., Benko S., Szatmari I., Balint B.L., Furtos I., Ruhl R., Molnar S., Csiba L., Garuti R., Calandra S., Larsson H., Diczfalusy U., Nagy L. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol. 2004, 24:8154-8166.
24. Chen M., Bradley M.N., Beaven S.W., Tontonoz P. Phosphorylation of the liver X receptors. FEBS Lett. 2006, 580:4835-4841.
25. Torra I.P., Ismaili N., Feig J.E., Xu C.F., Cavasotto C., Pancratov R., Rogatsky I., Neubert T.A., Fisher E.A., Garabedian M.J. Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol. Cell. Biol. 2008, 28:2626-2636.